← Leaderboards
Judith Agudo Cantero
Dana-Farber Cancer Inst
$1,780,000
Attributed
$1,780,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $445K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,780,000 · 1
By mechanism
R01$1,780,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Kai W Wucherpfennig$37,935,181
- Piotr Sicinski$42,703,610
- Shannon J Turley$5,420,711
- Donald W. Kufe$50,160,456
- Wayne A. Marasco$43,896,916
Others in their field
Other Rising Stars on “Exhaustion”
- Richard Pendleton · Leidos Biomedical Research, Inc.$11,154,254
- Andras A. Heczey · Baylor College Of Medicine$2,725,684
- Debattama Rai Sen · Massachusetts General Hospital$2,502,000
- Nana Kwaku Minkah · Seattle Children'S Hospital$2,456,734
- Arta Monir Monjazeb · University Of California At Davis$2,398,453
- Ming Yang · Mucommune, Llc$2,178,184
Research focus
ExhaustionExpectationAntigensAntigen PresentationAnergyApoptosisAutoantigensAutoimmune DiseasesAntigen TargetingAutomobile DrivingAutoreactive T CellAntigen-Presenting CellsBeta CellCd8-Positive T-LymphocytesCellsCell TypeClinicCytotoxic T-LymphocytesAutoimmunityDendritic CellsDiabetic MouseEngineeringEnsureFace
Grant awards (4)
Engineering dendritic cells to target islet antigen to pro-tolerogenic subsets for prevention and treatment of Type 1 Diabetes$445,000
R01 · FY2025 · DK · contact PI
Engineering dendritic cells to target islet antigen to pro-tolerogenic subsets for prevention and treatment of Type 1 Diabetes$445,000
R01 · FY2024 · DK · contact PI
Engineering dendritic cells to target islet antigen to pro-tolerogenic subsets for prevention and treatment of Type 1 Diabetes$445,000
R01 · FY2023 · DK · contact PI
Engineering dendritic cells to target islet antigen to pro-tolerogenic subsets for prevention and treatment of Type 1 Diabetes$445,000
R01 · FY2022 · DK · contact PI